Search Results - Callum Sloss

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    PB1888: TRIAL IN PROGRESS: PHASE 1B/2 STUDY OF PIVEKIMAB SUNIRINE (PVEK, IMGN632) IN COMBINATION WITH VENETOCLAX/AZACITIDINE OR MAGROLIMAB FOR PATIENTS WITH CD123-POSITIVE ACUTE MY... by Naval Daver, Pau Montesinos, Ahmed Aribi, Giovanni Martinelli, Eunice Wang, Jessica Altman, Gail Roboz, Patrick Burke, Roland Walter, Kebede Benga, Callum Sloss, Kara Malcolm, Patrick Zweidler-Mckay, Kendra Sweet

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  2. 2

    S139: INTERIM ANALYSIS OF A REGISTRATION ENABLING STUDY OF PIVEKIMAB SUNIRINE (PVEK, IMGN632) A CD123-TARGETING ANTIBODY-DRUG CONJUGATE, IN PATIENTS WITH BLASTIC PLASMACYTOID DENDR... by Naveen Pemmaraju, Giovanni Martinelli, Pau Montesinos, Luca Mazzarella, Daniel J. Deangelo, Harry Erba, Kendra Sweet, Roland Walter, Eric Deconinck, Ollivier Legrand, Eunice Wang, Ahmed Aribi, Matthew Ulrickson, Giovanni Marconi, Andrew Lane, Hagop Kantarjian, Callum Sloss, Kara Malcolm, Patrick Zweidler-Mckay, Naval Daver

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  3. 3

    PI3Kδ activation, IL-6 overexpression, and CD37 loss cause resistance to naratuximab emtansine in lymphomas by Alberto J. Arribas, Sara Napoli, Eugenio Gaudio, Charles Herbaux, Eleonora Cannas, Chiara Tarantelli, Roberta Bordone-Pittau, Luciano Cascione, Nicolas Munz, Luca Aresu, Jacopo Sgrignani, Andrea Rinaldi, Ivo Kwee, Davide Rossi, Andrea Cavalli, Emanuele Zucca, Georg Stussi, Anastasios Stathis, Callum Sloss, Matthew S. Davids, Francesco Bertoni

    Published in Blood Advances (2024-12-01)
    Get full text
    Article


Search Tools: